Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
DKSH Holding AG (DKSH.SW)
Zurich, ZH, CH
DKSH Holding AG provides various market expansion services in Thailand, Greater China, Malaysia, Singapore, rest of the Asia Pacific, and internationally. The company offers sourcing, market insights, marketing, sales, e-Commerce, distribution, logistics, and after sales services. It operates through four segments: Healthcare, Consumer Goods, Performance Materials, and Technology. The Healthcare segment provides various services, such as registration, regulatory, market entry studies, importation, customs clearance, marketing and sales, physical distribution, invoicing, and cash collection services for pharmaceuticals, consumer health, and over-the-counter health products, as well as medical devices. The Consumer Goods segment offers a range of services, including product feasibility studies, registration, importation, customs clearance, marketing and merchandising, sales, warehousing, physical distribution, invoicing, cash collection, and after-sales services for fast moving consumer goods, food services, luxury goods, and lifestyle products, as well as hair and skin cosmetics. The Performance Materials segment sources, markets, and distributes a range of specialty chemicals and ingredients for the pharmaceutical, personal care, food and beverage, and industrial applications, as well as provides market expansion services for performance materials. The Technology segment offers market expansion services comprising a range of capital investment goods and analytical instruments in the areas of infrastructure, industrial materials and supplies, precision and textile machinery, semiconductors, photovoltaic and electronics, agriculture, and hospitality, as well as specialized industrial applications. The company was founded in 1865 and is based in Zurich, Switzerland.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.74% | -1.74% | +4.03% | -0.48% | +10.52% | +5.80% | -3.43% | -5.56% | -15.36% | -0.88% | +21.57% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 5 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Distribution: +5.6%-0.2% Q4'25: +2.0% (vs Q4'23)
-
EPS growth Medical - Distribution: +4.9%-5.5% Q4'25: +51.2% (vs Q4'23)
-
FCF margin FCF growth · Medical - Distribution: +37.6%+2.4% Q4'25: +2.4% (vs Q4'23)
-
EBIT margin Medical - Distribution: +3.0%+2.9% Q4'25: +2.7% (vs Q4'23)
-
ROIC Medical - Distribution: +5.7%+10.1% ★ Q4'25: +19.4% (vs Q4'23)
-
Share dilution Medical - Distribution: +0.0%+0.0% Q4'25: -3.7% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Distribution: 0.87×2.15× Q4'25: 0.96× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 5 EPS Ana. |
Dec 2027 7 Rev. Ana. 5 EPS Ana. |
Dec 2028 6 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
8.83B
est: 8.72B (+1.3%)
|
9.58B
est: 9.88B (-3.0%)
|
9.82B
est: 9.88B (-0.6%)
|
10.05B
est: 10.05B (+0.0%)
|
10.51B
est: 10.45B (+0.5%)
|
11.02B
est: 11.00B (+0.2%)
|
11.36B
est: 11.66B (-2.6%)
|
11.58B
est: 11.50B (+0.7%)
|
10.74B
est: 10.94B (-1.8%)
|
11.11B
est: 11.06B (+0.4%)
|
11.32B
est: 11.27B (+0.5%)
|
11.07B
est: 10.90B (+1.5%)
|
11.09B
est: 11.07B (+0.2%)
|
11.07B
est: 11.02B (+0.4%)
|
11.23B
11.05B – 11.42B
+1.9% YoY
|
11.62B
11.32B – 11.89B
+3.4% YoY
|
12.03B
12.01B – 12.05B
+3.6% YoY
|
| EBITDA |
337.10M
est: 342.72M (-1.6%)
|
302.30M
est: 347.38M (-13.0%)
|
285.20M
est: 339.36M (-16.0%)
|
251.60M
est: 309.56M (-18.7%)
|
312.50M
est: 366.04M (-14.6%)
|
310.40M
est: 335.53M (-7.5%)
|
318.20M
est: 326.93M (-2.7%)
|
385.60M
est: 358.00M (+7.7%)
|
371.00M
est: 329.40M (+12.6%)
|
460.60M
est: 347.53M (+32.5%)
|
437.30M
est: 360.49M (+21.3%)
|
434.90M
est: 432.36M (+0.6%)
|
472.00M
est: 439.01M (+7.5%)
|
438.30M
est: 437.34M (+0.2%)
|
445.45M
438.35M – 453.04M
+1.9% YoY
|
460.77M
449.18M – 471.78M
+3.4% YoY
|
477.25M
476.32M – 478.19M
+3.6% YoY
|
| EBIT |
295.80M
est: 241.39M (+22.5%)
|
258.90M
est: 339.79M (-23.8%)
|
272.10M
est: 311.96M (-12.8%)
|
280.00M
est: 282.36M (-0.8%)
|
299.10M
est: 281.47M (+6.3%)
|
296.40M
est: 320.64M (-7.6%)
|
339.00M
est: 321.85M (+5.3%)
|
254.40M
est: 333.86M (-23.8%)
|
245.60M
est: 258.42M (-5.0%)
|
326.50M
est: 272.64M (+19.8%)
|
310.70M
est: 282.81M (+9.9%)
|
302.80M
est: 317.25M (-4.6%)
|
345.40M
est: 322.13M (+7.2%)
|
316.60M
est: 320.90M (-1.3%)
|
326.85M
321.64M – 332.42M
+1.9% YoY
|
338.09M
329.59M – 346.17M
+3.4% YoY
|
350.19M
349.50M – 350.87M
+3.6% YoY
|
| Net Income |
201.20M
est: 183.05M (+9.9%)
|
228.70M
est: 226.53M (+1.0%)
|
192.20M
est: 228.97M (-16.1%)
|
202.60M
est: 198.58M (+2.0%)
|
208.60M
est: 210.50M (-0.9%)
|
207.00M
est: 220.24M (-6.0%)
|
254.80M
est: 219.23M (+16.2%)
|
172.60M
est: 251.08M (-31.3%)
|
157.10M
est: 168.06M (-6.5%)
|
223.90M
est: 177.31M (+26.3%)
|
201.10M
est: 201.70M (-0.3%)
|
182.00M
est: 189.80M (-4.1%)
|
214.80M
est: 213.46M (+0.6%)
|
202.90M
est: 226.35M (-10.4%)
|
236.38M
212.59M – 255.48M
+4.4% YoY
|
254.37M
249.05M – 275.34M
+7.6% YoY
|
276.68M
271.36M – 281.99M
+8.8% YoY
|
| SGA |
350.90M
est: 259.23M (+35.4%)
|
377.10M
est: 1.19B (-68.3%)
|
368.80M
est: 1.09B (-66.3%)
|
370.20M
est: 1.12B (-67.0%)
|
363.50M
est: 1.16B (-68.6%)
|
375.00M
est: 1.22B (-69.3%)
|
343.00M
est: 1.29B (-73.4%)
|
357.20M
est: 1.23B (-70.9%)
|
351.80M
est: 1.11B (-68.2%)
|
361.40M
est: 1.17B (-69.1%)
|
331.30M
est: 1.21B (-72.7%)
|
301.60M
est: 307.45M (-1.9%)
|
297.40M
est: 312.18M (-4.7%)
|
278.70M
est: 310.99M (-10.4%)
|
316.76M
311.71M – 322.16M
+1.9% YoY
|
327.65M
319.41M – 335.48M
+3.4% YoY
|
339.37M
338.71M – 340.04M
+3.6% YoY
|
| EPS |
3.16
est: 2.81 (+12.3%)
|
3.57
est: 3.20 (+11.7%)
|
2.96
est: 3.01 (-1.6%)
|
3.11
est: 3.07 (+1.2%)
|
3.21
est: 2.95 (+8.9%)
|
3.18
est: 3.13 (+1.5%)
|
3.92
est: 3.11 (+26.0%)
|
2.65
est: 2.71 (-2.1%)
|
2.42
est: 2.42 (+0.2%)
|
3.45
est: 2.82 (+22.3%)
|
3.10
est: 3.18 (-2.6%)
|
2.80
est: 2.92 (-4.2%)
|
3.30
est: 3.28 (+0.5%)
|
3.12
est: 3.43 (-9.1%)
|
3.61
3.27 – 3.93
+5.1% YoY
|
3.95
3.83 – 4.23
+9.5% YoY
|
4.27
4.17 – 4.34
+8.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | First Trust Switzerland AlphaDEX Fund FSZ | 2.73% | 1.01M | 0.80% |
| 2 | First Trust S&P International Dividend Aristocrats ETF FID | 1.27% | 2.03M | 0.60% |
| 3 | Fidelity European Trust PLC FEV.L | 1.06% | 26.68M | 0.27% |
| 4 | UBS S&P Dividend Aristocrats ESG Elite UCITS ETF USD dis UBUM.DE | 1.03% | 2.12M | 0.30% |
| 5 | State Street SPDR S&P Global Dividend ETF WDIV | 0.93% | 2.49M | 0.40% |
| 6 | State Street SPDR S&P Global Dividend Aristocrats Screened UCITS ETF (Dist) GEDV.L | 0.71% | 171.4K | 0.45% |
| 7 | iShares Swiss Dividend ETF (CH) CHDVD.SW | 0.51% | 50.19M | 0.15% |
| 8 | iShares STOXX Europe Small 200 UCITS ETF (DE) EXSE.DE | 0.39% | 2.65M | 0.20% |
| 9 | State Street SPDR MSCI Europe Small Cap Value Weighted UCITS ETF EUR Acc ZPRX.DE | 0.25% | 1.91M | 0.30% |
| 10 | iShares MSCI Europe Small-Cap ETF IEUS | 0.19% | 328.4K | 0.41% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Stefan Butz | Chief Executive Officer | 3M | male |
| Chris Ritchie | Head of Business Unit Consumer Goods | — | male |
| Delia Sun | Head Supply Chain Management | — | female |
| Hanno Elbraechter | Head of Business Unit Technology | — | male |
| Ido Wallach | Vice President of Group Controlling & Chief Financial Officer | — | male |
| Jasprit Sahnsi | General Counsel | — | female |
| Natale Capri | Head of the Business Unit Performance Materials | — | — |
| Sam Oh | Chief Information Officer | — | male |
| Antoine Mangin | Chief Human Resource Officer | — | male |
| Till Leisner | Head of Group Investor & Media Relations | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DKSH.SW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
